Genialis

Boston, MA · Privately Held (backing)

Developer of an AI-driven cancer biology platform designed to predict how therapies will perform in patients. Genialis is based in Boston, MA. Its last reported valuation was $37 million in Jan 2023. It has raised $16.4 million across 2 recorded rounds; the latest was a $700,000 seed round in Dec 2025.

Last reported valuation
$37.0M
Oct 2026
Priced at
—
Total raised
$16.4M
Last round
Seed Round
Dec 2025
How much has Genialis raised?
$16.4Macross 2 recorded rounds · Jan 2023 – Dec 2025

Most recently, Genialis raised $700K in its Seed Round (Dec 2025).

Free account
More of Genialis with a free account
  • ·Watch Genialis: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Genialis round by round

2 rounds
Dec 2025Seed Round$700KSEC filing▮
2 investors participated
Jan 2023Early Stage VC$11.4MSEC filing▮
10 investors participated

How much has Genialis raised?

Genialis has raised $16.4 million in total; 2 of its rounds are on record. The largest on record was a $700,000 seed round in Dec 2025.

Genialis has filed 1 Form D with the SEC, most recently in Jan 2023 ($11.4 million sold to 10 investors).

Genialis investors

9 investors are on record for Genialis, including Redalpine, Rajeev Surati, Debiopharm Innovation Fund and Drew Volpe. The seed round in Dec 2025 drew 2 investors.

For fundraisers
Raising for a company like Genialis?

9 investors have backed Genialis.

See all 9 investors →

Frequently asked about Genialis

How much has Genialis raised?
Genialis has raised $16.4M in total across 2 recorded funding rounds.
When was Genialis's last funding round?
Genialis's most recent recorded round was Seed Round in Dec 2025, raising $700K.